Data Limitations Morbidity based on reported positive lab result –Under-reporting of both acute and chronic infections Morbidity based on CDC case definitions.

Slides:

Advertisements

Similar presentations

1. Interpret a positive HBeAg, Anti- HBcAg, and/or anti-HCV test.

Advertisements

Saotharlann Náisiúnta Tagartha Viris UCD UCD National Virus Reference Laboratory Dr. Jeff Connell Assistant Director National Virus Reference Laboratory.

Factors associated to the prevalence of antibodies to hepatitis C virus in chronic hemodialysis patients in a sample of centers in Puerto Rico, 2005 Marievelisse.

Case Identification for the Missouri Perinatal Hepatitis B Prevention Program Libby Landrum, RN, MSN Viral Hepatitis Prevention Manager Bureau HIV, STD,

Investigation of a Cluster of Acute Hepatitis C Infections in IDUs, Minnesota, 2001 Minnesota Department of Health.

Texas Perinatal Hepatitis B Prevention Program 2 nd Bi-Annual State Conference Designing an Effective Case Management Program Lisa Jacques-Carroll, MSW.

Perinatal Hepatitis B Prevention

Chronic Hepatitis B Surveillance in Santa Clara County Sara H. Cody, MD Deputy Health Officer An evaluation to understand meaning and usefulness of surveillance.

Developmental Work Toward Implementation of a Master Patient Index Technical Perspectives and Lessons Learned from North Carolina “Working for a healthier.

Estimates of People with Hepatitis C in South Carolina Number People with Reactive anti-HCV Antibody United States Census Bureau 2010: Age and Sex Compositions.

TB Outbreak in Grand Forks

U.S. Surveillance Update Anthony Fiore, MD, MPH CAPT, USPHS Influenza Division National Center for Immunizations and Respiratory Disease Centers for Disease.

1 Lauren E. Finn, 2 Seth Sheffler-Collins, MPH, 2 Marcelo Fernandez-Viña, MPH, 2 Claire Newbern, PhD, 1 Dr. Alison Evans, ScD., 1 Drexel University School.

Hepatitis B: Epidemiology

Minnesota Department of Health HIV/AIDS Surveillance System HIGHLIGHTS FROM THE MN HIV SURVEILLANCE REPORT 2014.

Epidemiology and Prevention of Viral Hepatitis A to E: Hepatitis Branch Centers for Disease Control and Prevention An Overview.

HIV Infection Among Those with an Injection Drug Use*- Associated Risk, Florida, 2012 Florida Department of Health HIV/AIDS and Hepatitis Section Division.

Chronic Hepatitis B Surveillance Kathleen Harriman California Department of Public Health Immunization Branch November 1, 2012.

The Changing Epidemiology of Acute Hepatitis A in Texas Rachel Wiseman, MPH, Lucille Palenapa, MS; Linda Gaul, PhD Emerging and Acute Infectious Disease.

Factors associated with hepatitis B serologic screening in a population- based survey of Korean Americans from Washington state Adeena Khan, MD 1 Genji.

Infectious Disease Epidemiology Section Office of Public Health Louisiana Department of Health and Hospitals

Infant Mortality Linked Birth-Infant Death Data Set Tulsa County, Oklahoma Preliminary Findings Carol Kuplicki, MPH Community Service Council.

Unmet Need for Hepatitis C PCR Testing, New York City, Emily McGibbon, MPH June 2011 CSTE Annual Conference.

Wyoming Department of Health Communicable Diseases

Hepatitis B Virus 28.

World Hepatitis Day 2013, 29 th July Establishing a framework for better data collection and surveillance of Hepatitis in South Africa N. Prabdial-Sing.

Office of Epidemiology and Prevention Services DIVISION OF INFECTIOUS DISEASE EPIDEMIOLOGY The Burden of Hepatitis C in West Virginia November.

A Cluster of Hepatitis C among Rural, Young Adults – Illinois, 2012 Julia Howland, MPH CPH CDC/CSTE Applied Epidemiology Fellow Illinois Department of.

Grace Van Ness, MPH, CHES, Ann Thomas, MD, MPH & Sharon Vance

ArHIP © Hep-C ALERT, Inc. arHIP Hep-C ALERT, Inc. Addiction Recovery Hepatitis Intervention Project.

North Dakota Department of Health STD Program Update Region 8 GC Control Meeting November 2009.

Enhanced Hepatitis Strain & Surveillance System (EHSSS) in Review BCCDC Hepatitis Site Site Investigator: Liza McGuinness.

Sexually Transmitted Disease Epidemiology in North Dakota Chlamydia, Gonorrhea, Hepatitis C, Syphilis and HIV Lindsey VanderBusch STD/HIV/TB/Hepatitis.

Session 3: Assessment & Evaluation Lisa Jacques-Carroll, MSW NCIRD, CDC.

Occult hepatitis B virus (HBV) and hepatitis C virus (HCV) viremia in women with and at-risk for HIV/AIDS Taylor L, Gholam P, Delong A, Rompalo A, Klein.

STDs among Men who Have Sex with Men (MSM), San Francisco 2007—2010 STD Prevention and Control Services San Francisco Department of Public Health.

Sarah Weninger Adult Viral Hepatitis Prevention Coordinator Division of Disease Control Phone:

I AM NOT HOMELESS CSTE JUNE 2013 Dee Pritschet, TB Controller – North Dakota Department of Health Shawn McBride, Epidemiologist – North Dakota Department.

Scioto County Medical Society Grand Rounds March 31, 2006 Portsmouth, Ohio Kathleen M. Koechlin, RN, MPH, PhD Hepatitis C Coordinator The Ohio Department.

2007 Viral Hepatitis Data. Data Limitations Morbidity based on reported positive lab result Morbidity based on reported positive lab result –Under-reporting.

2011 Viral Hepatitis Data. Data Limitations Morbidity based on reported positive lab result Morbidity based on reported positive lab result –Under-reporting.

Tuberculosis in North Dakota 2011 Craig Steffens, MPH TB/HIV Surveillance Coordinator.

2014 HIV.STD.TB.Viral Hepatitis Symposium. Program Staff Lindsey VanderBusch – Program Manager Sarah.

Assessing the public health challenge posed by Hepatitis B and C in the EU European Centre for Disease Prevention and Control Information for members of.

SPECIAL CONSIDERATIONS August

Hepatitis B The Basics David Wong University of Toronto March 2005.

Evaluation of Hepatitis B surveillance system in Armenia, 2014 AUTHORS Karine Gevorgyan Lusine Paronyan Shushan Sargsyan Artavazd Vanyan NCDC, Armenia.

Lessons from Indiana HIV and Hepatitis C Wisconsin HIV Community Planning Statewide Action Planning Group Meeting Green Lake June 25,

Integrating Hepatitis Screening and Immunizations in the STD clinic Palm Beach County, Florida National Immunization Conference March 8, 2007 Savita Kumar.

Acute Renal Failure in HIV- Infected Individuals Greatly Increases Risk for In-Hospital Mortality Slideset on: Wyatt CM, Arons RR, Klotman PE, Klotman.

| Web: The findings and conclusions in this report are those of the authors and do not necessarily represent the official.

The Geography of Viral Hepatitis C In Texas, Mara Hedrich

Non-Medical Staff Knowledge, Beliefs and Practices about HIV and Hepatitis for Injection Drug Users Rowe, KA 1, Tesoriero, JM 1, Heavner, KK 1, Rothman,

Prevention of Perinatal and Childhood Hepatitis B Virus Infections Background on Where We’ve Been Lisa Jacques-Carroll, MSW Immunization Services Division,

Adult Hepatitis A and B Vaccination in Traditional and Non-Traditional Sites, North Carolina Beth Rowe-West, Head Immunization Branch Division of Public.

HIV/AIDS Surveillance System Highlights from the MN HIV Surveillance Report, 2015 Sexually Transmitted Diseases, HIV and Tuberculosis Section, Epidemiology.

County of Los Angeles Department of Health Services IMMUNIZATION PROGRAM Using Non-Traditional Immunization Settings to Immunize.

Hepatitis C Virus Program in Chicago

Hepatitis C Surveillance: From nothing to something...

Pengjun Lu, PhD, MPH;1 Kathy Byrd, MD, MPH;2

State of the State: HIV, STDs and Viral Hepatitis 2016

Case Definition: HEPATITIS C

Expanding the Universe of Viral Hepatitis Treaters

Number of HCV tests conducted

Hepatitis C Tennessee Caring Ambassadors, Senate Briefing May 18, 2018

Progress in Facilitating National HCV Prevention

May 9, 2006 National STD Prevention Conference

Volume 126, Issue 4, Pages (April 2004)

Incidence of HCC after HCV treatment with DAAs: ERCHIVES

Presentation transcript:

Data Limitations Morbidity based on reported positive lab result –Under-reporting of both acute and chronic infections Morbidity based on CDC case definitions –“Hepatitis C virus infection, past or present” Numbers do not distinguish between resolved vs. active infections –“Hepatitis B virus infection, chronic” Includes “confirmed” and “probable” cases Follow-up includes collection of basic demographics and county of residence, at a minimum –Case interview and partner notification not included Year 2005 is baseline year for data (due to implementation of new electronic reporting system, DREAMS, and more stringent follow-up) –Current data not de-duplicated with years prior to 2005

Cases Reported to ND Department of Health (2005 Morbidity) OutcomeHAVHBVHCV Acute infections301 Chronic infections Cumulative total (through 2005) * (chronic) 3118* (chronic) *2005 is baseline year for reported positive lab results for HBV & HCV data not de-duplicated with previous years.

Cases Reported to ND Department of Health (2006 Morbidity) OutcomeHAVHBVHCV Acute infections310 Chronic infections Cumulative total (through 2006) * (chronic) 3696* (chronic) *2005 is baseline year for reported positive lab results for HBV & HCV data not de-duplicated with years prior to 2005.

2006 Hepatitis C Data

*Includes acute and “past or present” infections

North Dakota Hepatitis C Cases* by Gender Year 2006, N=578 *Based on reported positive lab result

North Dakota Hepatitis C Cases* by Age Group Year 2006, N=578 † *Based on reported positive lab result †Age unknown for 1 case

North Dakota Hepatitis C Cases* by Race Year 2006, N=578^ *Based on reported positive lab result ^Race reported for 61% of reported cases

2006 Hepatitis B Data

*Includes acute and chronic infections

North Dakota Hepatitis B Cases* by Gender Year 2006, N=61 *Based on reported positive lab result

North Dakota Hepatitis B Cases* by Age Group Year 2006, N=61 *Based on reported positive lab result

North Dakota Hepatitis B Cases* by Race Year 2006, N=61^ *Based on reported positive lab result ^Race reported for 52% of reported cases